Adropin a candidate diagnostic biomarker for cardiovascular disease in patients with chronic kidney disease

Maha Abd El Moneem Elfedawy, Samia Abd El Sadek Elsebai, Hend Mohamed Tawfik, Eman Refaat Youness, Moushira Zaki · 2024

Read Adropin a candidate diagnostic biomarker for cardiovascular disease in patients with chronic kidney disease by Maha Abd El Moneem Elfedawy, Samia Abd El Sadek Elsebai, Hend Mohamed Tawfik, Eman Refaat Youness, Moushira Zaki (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11703640.txt.

Description

Maha Abd El Moneem Elfedawy and co-authors test a hormone as a blood flag for heart disease in kidney patients, in a 2024 study. Heart disease is the top killer of people with chronic kidney disease. The hormone adropin, made by a gene tied to energy balance, had hinted at a link. The team drew blood from 60 kidney patients and 30 healthy peers.

Patients with a heart disease past formed one group, and those without formed another. Adropin ran far lower in the heart group than in the other patients and the healthy group. Fat and inflammation markers ran higher in that group too. A cutoff on adropin sorted the groups with fair, not strong, skill. Heart tracings were off in most kidney patients. The authors call adropin a candidate flag worth more study, not a settled test.

Catalog record

CREATORMaha Abd El Moneem Elfedawy, Samia Abd El Sadek Elsebai, Hend Mohamed Tawfik, Eman Refaat Youness, Moushira Zaki
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE21 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11703640

Browse the full library · About the Tower of Babel